Study Examines Effects of EMFUSION’s Patented DYNAMiQ Technology on Skin Barrier Restoration

A clinical study published in the Journal of Cosmetic Dermatology examines the effects of EMFUSION’s patented DYNAMiQ technology on skin barrier restoration and hydration.

The study involved 24 participants aged between 26 and 64 who underwent a single 30-minute EMFUSION treatment. Researchers assessed transepidermal water loss (TEWL) at baseline, immediately after treatment and again seven days later.

According to the published findings, the procedure resulted in an 80% improvement in skin barrier function following treatment. Researchers also reported that baseline TEWL values were 1.8 times higher than those recorded seven days after the procedure, indicating improved moisture retention and hydration.

Participant feedback from the study showed that 96% of subjects reported more hydrated and nourished skin, while all participants described the treatment as comfortable.

The publication adds to growing industry interest in skin barrier restoration and skin longevity treatments, areas increasingly recognised by dermatologists and aesthetic practitioners as important components of long-term skin health.

Unlike conventional aesthetic procedures that primarily target deeper tissue structures, EMFUSION is designed specifically to restore and strengthen the skin barrier. The technology uses patented DYNAMiQ technology to convert electric energy into mechanical waves that create skin resonance, with the aim of supporting epidermal homeostasis, enhancing ingredient absorption and improving hydration without aggressive exfoliation or downtime.

Commenting on the publication, Dee McMahon said, “This publication marks a major milestone for EMFUSION and for the future of skin longevity treatments. Having our clinical data published in such a respected peer-reviewed journal further reinforces the science behind EMFUSION and validates the importance of skin barrier health in aesthetic medicine.”

She added, “We are incredibly proud that Ireland was the first European market to launch this ground-breaking technology.”

The EMFUSION treatment follows a four-step skin barrier restoration process designed to support hydration and epidermal repair. The first stage, Refine, removes impurities and degraded skin barrier remnants, followed by Activate, which aims to restore epidermal homeostasis and support barrier repair. The Fuse stage enhances the delivery and absorption of ingredients including hyaluronic acid, niacinamide, allantoin and glycerin, while the final stage, Seal, locks in hydration and reinforces the skin barrier using ceramides, fatty acids and ectoin.

Since launching in Ireland earlier this year, the technology has attracted growing interest among aesthetic clinics seeking non-invasive skin health and prevention-focused treatments.

Consultant dermatologist, Caitriona Ryan, described the technology as “a transformative approach to restoring and strengthening the skin barrier, delivering lasting hydration and enhancing skin longevity for all skin types.”